Browse > Article

Prognostic Value of Vascular Endothelial Growth Factor (VEGF) and Basic Fibroblast Growth Factor (bFGF) Expression in Resected Non-small Cell Lung Cancer  

Kim, Seung Joon (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Lee, Jung Mi (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Kim, Jin Sook (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Kang, Ji Young (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Lee, Sang Hak (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Kim, Seok Chan (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Lee, Sook Young (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Kim, Chi Hong (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Ahn, Joong Hyun (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Kwon, Soon Seog (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Kim, Young Kyoon (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Kim, Kwan Hyoung (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Moon, Hwa Sik (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Song, Jeong Sup (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Park, Sung Hak (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Moon, Seok Hwan (Department of Thoracic and Cardiovascular Surgery, The Catholic University of Korea College of Medicine)
Wang, Yeong Pil (Department of Thoracic and Cardiovascular Surgery, The Catholic University of Korea College of Medicine)
Publication Information
Tuberculosis and Respiratory Diseases / v.64, no.3, 2008 , pp. 200-205 More about this Journal
Abstract
Background: Tumor angiogenesis plays an important role in tumor growth, maintenance and metastatic potential. Tumor tissue produces many types of angiogenic growth factors. Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) have both been implicated to have roles in tumor angiogenesis. In this study, the expression of tissue VEGF and bFGF from non-small cell lung cancer (NSCLC) patients were analyzed. Methods: We retrospectively investigated 35 patients with a histologically confirmed adenocarcinoma or squamous cell carcinoma of the lung, where the primary curative approach was surgery. An ELISA was employed to determine the expression of VEGF and bFGF in extracts prepared from 35 frozen tissue samples taken from the cancer patients. Results: VEGF and bFGF concentrations were significantly increased in lung cancer tissue as compared with control (non-cancerous) tissue. The VEGF concentration was significantly increased in T2 and T3 cancers as compared with T1 cancer. Expression of VEGF was increased in node-positive lung cancer tissue as compared with node-negative lung cancer tissue (p=0.06). VEGF and bFGF expression were not directly related to the stage of lung cancer and patient survival. Conclusion: Expression of VEGF and bFGF were increased in lung cancer tissue, and the expression of VEGF concentration in lung cancer tissue was more likely related with tumor size and the presence of a lymph node metastasis than the expression of bFGF. However, in this study, expression of both VEGF and bFGF in tissue were not associated with patient prognosis.
Keywords
VEGF; bFGF; Angiogenesis; Lung cancer; Prognosis;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Ravdin PM, Davis G. Prognosis of patients with resected non-small cell lung cancer: impact of clinical and pathologic variables. Lung Cancer 2006;52:207-12   DOI   ScienceOn
2 Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9   DOI
3 Klagsbrun M. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions. Semin Cancer Biol 1992;3:81-7
4 Ko HJ, Park JH, Shim H, Yang SH, Jeong ET. Prognostic value of vascular endothelial growth factor (VEGF) in resected non-small cell lung cancer. Tuberc Respir Dis 2001;50:676-85   DOI
5 Choi Y, Kim Y, Hong YC, Park SK, Yoo KY. Temporal changes of lung cancer mortality in Korea. J Korean Med Sci 2007;22:524-8   DOI   ScienceOn
6 Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-6   DOI   ScienceOn
7 Bremnes RM, Camps C, Sirera R. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer 2006;51:143-58   DOI   ScienceOn
8 Onn A, Herbst RS. Angiogenesis and lung cancer: implications for prognosis and treatment. Lancet Oncol 2007;8:460-1   DOI   ScienceOn
9 Iwasaki A, Kuwahara M, Yoshinaga Y, Shirakusa T. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC. Eur J Cardiothorac Surg 2004;25:443-8   DOI   ScienceOn
10 Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 2005;69 Suppl 3:4-10   DOI   ScienceOn
11 Hemmerlein B, Kugler A, Ozisik R, Ringert RH, Radzun HJ, Thelen P. Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas. Virchows Arch 2001;439:645-52   DOI
12 Tanaka F, Otake Y, Yanagihara K, Kawano Y, Miyahara R, Li M, et al. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 anti-body and anti-CD105 antibody. Clin Cancer Res 2001;7:3410-5
13 Ferrara N. The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS 2005;94:209-31
14 Cebe-Suarez S, Zehnder-Fjallman A, Ballmer-Hofer K. The role of VEGF receptors in angiogenesis: complex partnerships. Cell Mol Life Sci 2006;63:601-15   DOI
15 Kiselyov A, Balakin KV, Tkachenko SE. VEGF/VEGFR signalling as a target for inhibiting angiogenesis. Expert Opin Investig Drugs 2007;16:83-107   DOI   ScienceOn
16 Papetti M, Herman IM. Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 2002;282:C947-70   DOI
17 Cross MJ, Claesson-Welsh L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 2001;22:201-7   DOI   ScienceOn
18 Anderson IC, Mari SE, Broderick RJ, Mari BP, Shipp MA. The angiogenic factor interleukin 8 is induced in non-small cell lung cancer/pulmonary fibroblast cocultures. Cancer Res 2000;60:269-72
19 Rong Y, Durden DL, Van Meir EG, Brat DJ. 'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 2006;65:529-39   DOI
20 Szebenyi G, Fallon JF. Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol 1999;185:45-106
21 Lee SN. The prognostic role of vascular endothelial growth factor (VEGF) expression and angiogenesis in curatively resected non-small cell lung cancer. J Korean Cancer Assoc 1999;31:1210-8